Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Faculty Opinions recommendation of Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats. — Ralf Weiskirchen | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Faculty Opinions recommendation of Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.
RW
Shared by
Ralf Weiskirchen
Faculty Opinions recommendation of Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.
Dataset
en
Authors
RW
Ralf Weiskirchen
MH
Martin Hennenberg
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Dataset
Faculty Opinions recommendation of Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
Ralf Weiskirchen
Dataset
Faculty Opinions recommendation of Losartan prevents portal hypertension-induced, redox-mediated endothelial dysfunction in the mesenteric artery in rats.
Ralf Weiskirchen
,
Martin Hennenberg
DOI
10.3410/f.1165269.628217
Year
Published
—
Language
en
Dataset Details
Link Of The Paper
https://doi.org/10.3410/f.1165269.628217
Timeline
Created:
June 19, 2026
Dataset
Faculty Opinions recommendation of Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis.
Ralf Weiskirchen
Dataset
Faculty Opinions recommendation of GnRH replacement rescues cognition in Down syndrome.
George Chrousos
,
George Paltoglou
Dataset
Faculty Opinions recommendation of The amyloid cascade hypothesis.
George Perry
Discussion(0)
No comments yet. Be the first to comment.